Sponsored by the University of Medicine and Dentistry of New Jersey (UMDNJ), Center for Continuing and Outreach Education. This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.
This activity is designed for physicians and nurses, and for other healthcare
professionals in New Jersey who are involved in the care of adults and adolescents.
Statement of Need
HIV testing recommendations have changed significantly over the years, since HIV testing first became available in 1985, with the principal goal of protecting the blood supply. Special HIV test sites were established so people would not use blood banks to learn their HIV status. Since then, both HIV testing and treatment have become effective. The CDC currently recommends that all healthcare providers integrate HIV counseling and testing into routine practice.
HIV treatment success depends, in part, on timely diagnosis of infection. The CDC reports that during 2005, 38% of people diagnosed with AIDS had their initial positive HIV test less than one year earlier.1 The state of New Jersey has legislated “Opt-Out” HIV screening for all pregnant women, in the first and third trimesters of prenatal care, and testing of newborns whose mothers do not have an HIV test record.2
Clinicians and health administrators need current information about the most effective and efficient means to diagnose and confirm HIV infection, to implement expanded HIV testing programs in medical care. Increased testing and earlier diagnosis of HIV infection will reduce treatment delays for persons with HIV infection and help them to live longer and healthier lives.
1 Centers for Disease Control and Prevention: Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health Care Settings. MMWR 2006, 55 (RR14): 1-17.
2 Paul, S.M. and Dimasi, L.G. New Jersey’s New Legislation for HIV Testing of Pregnant Women and Newborns. New Jersey AIDSLine June 2008:1, 36.
Upon completion of this learning activity, the reader should be able to:
- Describe the most recent Centers for Disease Control and Prevention recommendations for HIV testing.
- Explain the indications for rapid HIV testing of women in labor and some newborns.
- Describe the licensing requirements for rapid HIV testing.
Method of Instruction
Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the self-assessment test which consists of a series of multiple-choice questions. Upon completing this activity as designed and achieving a passing score of 70% or more on the self-assessment test, participants will receive a credit letter via email. Estimated time to complete this activity as designed is 1.25 hours.
EXPIRED- CE is no longer available for this activity. This content is being provided for informational purposes only.
UMDNJ–Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 1.25 hours of AMA PRA category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity..
The University of Medicine and Dentistry of New Jersey-Continuing Education and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P173-10/06-09. New Jersey State Nurses Association is accredited by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.25 contact hours.
UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing education by the California Board of Registered Nursing, Provider Number CEP 13780 for a maximum of 1.25 contact hours for this activity.
This activity was peer reviewed for relevance, accuracy of content, and balance of presentation by Patricia Kloser, MD, MPH; Debbie Y. Mohammed, MS, MPH, APRN-BC, and Brenda Christian, MEd, PA-C; and pilot tested for relevance and time required for participation by Kinshasa Morton, MD; Bonnie Abedini, MSN, MS; Mary C. Krug, RN, MSN, APN-C; and Kara Winslow, BSN, RN.
Sindy M. Paul, MD, MPH, FACPM, is the Medical Director of the NJ Dept. of Health and Senior Services, Division of HIV/AIDS Services; Assistant Clinical Professor at the UMDNJ-School of Public Health and past President, New Jersey Board of Medical Examiners.
Eugene Martin, PhD, is Professor of Pathology and Laboratory Medicine at UMDNJRobert Wood Johnson Medical School and Administrative Director, University Diagnostic Laboratories (UDL) and UDL Subdirector, Point of Care Testing.
Activity Director(s)/CME Academic Advisor(s)
Patricia Kloser, MD, MPH
UMDNJ-New Jersey Medical School
- Sindy Paul, MD, MPH, FACPM, New Jersey Dept. of Health and Senior Services
- Debbie Y. Mohammed, MS, MPH, APRN-BC, UMDNJ-University Hospital
- Linda Berezny, RN, BA, New Jersey Dept. of Health and Senior Services
- Kimi Nakata, MSW, MPH, UMDNJ-CCOE
Faculty Disclosure Declarations
Debbie Mohammed has disclosed the following: she is on the speaker’s bureaus of BMS and Gilead.
Conflicts of interest were resolved by review by Activity Director Patricia Kloser, MD, MPH.
The following have no financial relationships to disclose: Activity Director Patricia Kloser, MD, MPH; Planning committee members Sindy M. Paul, MD, MPH, FACPM; Linda Berezny, RN, BA; and Kimi Nakata, MSW, MPH (editor); content reviewer Brenda Christian, MEd, PA-C; and field testers: Kinshasa Morton, MD; Bonnie Abedini, BSN, MS; Mary C. Krug. RN, MSN, APN-C; and Kara Winslow, BSN, RN.
Off-Label Usage Disclosure
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDHSS-Division of HIV/AIDS Services, UMDNJ, or any manufacturer of pharmaceuticals. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.
Copyright ©2009 UMDNJ-Center for Continuing and Outreach Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any formor by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing and Outreach Education. Please direct CME related questions to UMDNJ at 973-972-4267 or email email@example.com.